Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons

Molecular Pharmacology

Volumn 64, Issue 2, 2003, Pages 202-210

  Zöllner, Christian ^a   Shaqura, M A ^a   Bopaiah, C P ^a   Mousa, S ^a   Stein, C ^a   Schafer M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FREUND ADJUVANT; G PROTEIN COUPLED RECEPTOR; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE;

ANALGESIC ACTIVITY; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; INFLAMMATION; MALE; MUSCLE SPINDLE AFFERENT NERVE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SPINAL GANGLION;

ANIMALS; BEHAVIOR, ANIMAL; BINDING SITES; BUPRENORPHINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GANGLIA, SPINAL; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEURONS, AFFERENT; PAIN; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SCIATIC NERVE; SULFUR RADIOISOTOPES;

EID: 0041341960     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.2.202     Document Type: Article

References (28)

1. Antonijevic I, Mousa SA, Schafer M, and Stein C (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165-172.
2. Chavkin C and Goldstein A (1984) Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci USA 81:7253-7257.
3. Gopal S, Tzeng TB, and Cowan A (2002) Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine. Eur J Pharm Sci 15:287-293.
4. Hassan AH, Ableitner A, Stein C, and Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185-195.
5. Huang P, Kehner GB, Cowan A, and Liu-Chen LY (2001) Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 297:688-695.
6. Ji RR, Zhang Q, Law PY, Low HH, Elde R, and Hokfelt T (1995) Expression of mu-, delta- and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
7. Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W. and Hollt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901-43908.
8. Laduron PM and Castel MN (1990) Axonal transport of receptors. A major criterion for presynaptic localization. Ann NY Acad Sci 604:462-469.
9. Law PY, McGinn TM, Wick MJ, Erikson LJ, Evans C, and Loh HH (1994) Analysis of δ-opioid receptor activities stably expressed in CHO cell lines: Function of receptor density? J Pharmacol Exp Ther 271:1686-1694.
10. Mousa SA, Zhang Q, Sitte N, Ji R, and Stein C (2001) Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-78.
11. 35S]Guanosine-5′-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. J Pharmacol Exp Ther 282:181-191.
12. 1B receptor/G-protein stoichiometry. Mol Pharmacol 58:1042-1049.
13. Newman-Tancredi A, Conte C, Chaput C, Verriele L, and Millan MJ (1997b) Agonist and inverse agonist efficacy at human recombinant Serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry. Neuropharmacology 36:451-459.
14. 35S]thio)-triphosphate binding and antibody study. Mol Pharmacol 55:564-574.
15. Prather PL, McGinn TM, Erickson LJ, Evans CJ, Loh HH, and Law PY (1994) Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J Biol Chem 269:21293-21302.
16. Remmers AE, Clark MJ, Alt A, Medzihradsky F, Woods JH, and Traynor JR (2000) Activation of G protein by opioid receptors: role of receptor number and g-protein concentration. Eur J Pharmacol 396:67-75.
17. 35S]GTPγS binding in MOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496-505.
18. Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, and Sim-Selley LJ (2001) Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77:1048-1057.
19. Selley DE, Sim LJ, Xiao R, Liu Q, and Childers SR (1997) μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87-96.
20. Sim LJ, Selley DE, Xiao R, and Childers SR (1996) Differences in G-protein activation by mu- and delta-opioid and cannabinoid, receptors in rat striatum. Eur J Pharmacol 307:97-105.
21. Stein C, Machelska H, Binder W, and Schafer M (2001) Peripheral opioid analgesia. Curr Opin Pharmacol 1:62-65.
22. Stein C, Millan MJ, and Herz A (1988b) Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31:455-461.
23. Stein C, Millan MJ, Shippenberg TS, and Herz A (1988a) Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neurosci Lett 84:225-228.
24. Stein C, Millan MJ, Shippenberg TS, Peter K, and Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of μ, δ, and κ receptors. J Pharmacol Exp Ther 248:1269-1275.
25. Traynor JR, Clark MJ, and Remmers AE (2002) Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists. J Pharmacol Exp Ther 300:157-161.
26. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
27. Zaki PA, Keith DE Jr, Brine GA, Carroll FI, and Evans CJ (2000) Ligand-induced changes in surface μ-opioid receptor number: relationship to G protein activation? J Pharmacol Exp Ther 292:1127-1134.
28. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.